Related Experiment Videos
Microsporidia and human infections
1College of Veterinary Medicine, Texas A&M University, College Station 77843.
Abstract:
Protozoa of the phylum Microspora are obligate intracellular pathogens that are being detected with increasing frequency in humans, especially in patients with acquired immunodeficiency syndrome. Organisms from four genera have been reported to date, and serological data suggest the occurrence of latent infections. Sources of human infections are not known, but microsporidia are widespread in lower vertebrates and invertebrates. There is no known treatment. Study of the disease in mammals suggests that infection often will be clinically silent, that intact T-cell-mediated host defenses are required for resistance, and that serious clinical disease may occur under circumstances in which extensive parasite replication can occur.
Insights
Microsporidia, obligate intracellular pathogens, are increasingly found in humans, particularly those with AIDS. Currently, no treatments exist, and infection sources remain unknown.
Area of Science:
- Microbiology
- Infectious Diseases
- Parasitology
Background:
- Microsporidia are obligate intracellular protozoan pathogens.
- Increasing detection in humans, especially immunocompromised individuals (e.g., AIDS patients).
- Four genera identified; serological evidence suggests latent infections.
Purpose of the Study:
- To summarize the current understanding of microsporidia as human pathogens.
- To highlight the challenges in diagnosis and treatment.
- To discuss host defense mechanisms and disease progression.
Main Methods:
- Review of existing literature on microsporidian infections in humans and mammals.
- Analysis of serological data.
- Synthesis of findings on host-parasite interactions.
Main Results:
- Microsporidia are increasingly identified as human pathogens.
- Human infection sources are largely unknown, though widespread in other hosts.
- No effective treatments are currently available.
- Host immune status, particularly T-cell mediated immunity, is critical in determining disease outcome.
- Infections can be clinically silent or severe depending on parasite replication.
Conclusions:
- Microsporidiosis is an emerging opportunistic infection, especially in immunocompromised patients.
- Further research is needed to identify sources of human infection and develop treatments.
- Maintaining intact host immune defenses is crucial for controlling microsporidian infections.